Articles from Caixin Global, Caixin Global

Caixin Global

Articles from Caixin Global

Caixin is a media group dedicated to providing financial and business news through periodicals, online content, mobile apps, conferences, books and TV/video programs. Caixin aims to blaze a trail that helps traditional media prosper in the new media age through integrated multimedia platforms.

News from Caixin

Cross Asset Strategy

<ul>
<li>
In Depth: Behind the massive sell-off in Chinese wealth management products.
</li>
<li>
Pfizer CEO dismisses reports of a Paxlovid generic for China.
</li>
<li>
Local governments set to borrow $146 billion in first quarter.
</li>
</ul>



In Depth: Behind the massive sell-off in Chinese wealth management products.


Pfizer CEO dismisses reports of a Paxlovid generic for China.


Local governments set to borrow $146 billion in first quarter.



CX Daily: Behind the Massive Sell-Off in Chinese Wealth Management Products

Geopolitical Analyst, Steno Research, Steno Research

Mikkel Rosenvold

Geopolitical Analyst, Steno Research

Macro and Geopolitical Research House

Steno Research

Steno Research is a new macro and geopolitical research house. We are based out of Copenhagen, Denmark, but have an international team and a strong network of sources and partners around the world. The team is lead by Andreas Steno, previous global head of strategy at Nordea Bank, and Mikkel Rosenvold, former chief consultant in the Danish Ministry of Finance.

Thematic (Sector/Industry)

<ul>
<li>At the dawn of the EV-revolution, Bolivia is at risk of being the first failed lithium state. </li>
<li>Elon Musk has been pointed out as one of the key suspects behind political crisis in the country.</li>
<li>Read why there is still a bullish case for Bolivian lithium.</li>
</ul>


At the dawn of the EV-revolution, Bolivia is at risk of being the first failed lithium state. 
Elon Musk has been pointed out as one of the key suspects behind political crisis in the country.
Read why there is still a bullish case for Bolivian lithium.


<ul><li>Cover Story: China’s international air travel resumes, but Covid turbulence to delay takeoff</li><li>Pfizer’s Paxlovid to be dropped from national subsidy program as talks collapse</li><li>Foreign Ministry spokesperson Zhao Lijian transferred to Ocean Affairs Department</li></ul>

Cover Story: China’s international air travel resumes, but Covid turbulence to delay takeoffPfizer’s Paxlovid to be dropped from national subsidy program as talks collapseForeign Ministry spokesperson Zhao Lijian transferred to Ocean Affairs Department

CX Daily: China’s International Air Travel Resumes, But Covid Turbulence to Delay Takeoff

Equity, Bottom-up Analyst, Investics Research

Sameer Taneja

Equity, Bottom-up Analyst

Investics Research

It is important to note that the information provided by Investics Research is based on publicly available data and own knowledge, which has been gathered and analyzed from a variety of sources. While every effort has been made to ensure the accuracy and completeness of the information provided, it is not guaranteed to be free from errors or omissions. All forecasts and estimates are based on information that has been obtained from public sources that are considered to be reliable. The sources include but are not limited to, company announcements, exchange filings, presentations, etc. Investics does not guarantee the accuracy and completeness of the forecasts, estimates, and/or other information.

Equity Bottom-up Research

Equity Bottom-Up

<ul>
<li>
<a href="https://www.smartkarma.com/entities/china-meidong-auto-holdings-limited" target="_blank" data-smartkarma-citation="entities:10795:1" rel="noopener">China MeiDong Auto (1268 HK)</a> raised 800mn HKD in a top placement (px~15 HKD/share), resulting in a ~4% dilution, citing an opportunistic raise for M&amp;A.</li>
<li>While the company asserts there is a well-defined pipeline, it was not very specific on the size and scope of its targets which was not taken well by the market.</li>
<li>We continue to like the company, trading at a 15x/9x PE FY22e/23e, with a 5.2%/8.8% dividend yield (assuming an 80% payout ratio), with the optionality of M&amp;A potential. </li>
</ul>



China MeiDong Auto (1268 HK) raised 800mn HKD in a top placement (px~15 HKD/share), resulting in a ~4% dilution, citing an opportunistic raise for M&amp;A.
While the company asserts there is a well-defined pipeline, it was not very specific on the size and scope of its targets which was not taken well by the market.
We continue to like the company, trading at a 15x/9x PE FY22e/23e, with a 5.2%/8.8% dividend yield (assuming an 80% payout ratio), with the optionality of M&amp;A potential. 


Meidong: Capital Raise, There's Never a Right Time

Founder & CEO Bond Angle, LLC, Bond Angle, LLC

Vicki Bryan

Founder & CEO Bond Angle, LLC

Bond Angle, LLC

Insightful commentary and analysis on bond markets and market movers, including financial, economic, and industry catalysts and management shenanigans. 

High yield market investment research

Credit

<ul>
<li>I've long warned 2H this year will mark passing of Tesla's dominance—mainly because the larger EV market is catching up and doing EV better. </li>
<li>Fading China sales &amp; Elon's Twitter mess has been taking it down even faster.</li>
<li>Q4 deliveries are due out next week, and they're likely to be ugly.</li>
</ul>


I've long warned 2H this year will mark passing of Tesla's dominance—mainly because the larger EV market is catching up and doing EV better. 
Fading China sales &amp; Elon's Twitter mess has been taking it down even faster.
Q4 deliveries are due out next week, and they're likely to be ugly.


United States

Tesla Inc. operates as a multinational automotive and clean energy company. The Company designs and manufactures electric vehicles, battery energy storage from home to grid-scale, solar panels and solar roof tiles, and related products and services. Tesla owns its sales and service network and sells electric power train components to other automobile manufacturers.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Tesla (TSLA US)

CX Daily: Behind the Massive Sell-Off in Chinese Wealth Management Products

In Depth: Behind the massive sell-off in Chinese wealth management products. Pfizer CEO dismisses reports of a Paxlovid generic for China.

Caixin Global

Bolivia: The First Failed Lithium-State

Bolivia is at risk of being the first 'failed lithium state'. Is Elon Musk to blame? Find out in this article, where I also explain why there is...

Steno Research

CX Daily: China’s International Air Travel Resumes, But Covid Turbulence to Delay Takeoff

Cover Story: China’s international air travel resumes, but Covid turbulence to delay takeoff. Pfizer’s Paxlovid to be dropped from national subsidy...

Caixin Global

Meidong: Capital Raise, There's Never a Right Time

Despite its capital raise, Meidong is still a great investment, trading at a 15x/9x PE FY22e/23e, with a 5.2%/8.8% dividend yield (assuming an 80%...

Sameer Taneja

Tesla Q4: Elon's Burning It All Down

I've long warned 2H this year will mark passing of Tesla's dominance—mainly cuz larger EV mkt is catching up & doing EV better. Fading China sales...

Vicki Bryan

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)